Directly measure & quantify degradation, selectivity, and mechanism for PROTACs and molecular glues.
How direct protein-level measurement of the tumor cell surface transforms target discovery.
On the use of comprehensive tumor proteomics to identify cancer targets and biology hiding beyond DNA and RNA.
Learn how protein-level evidence can augment or replace genomic inference at critical drug development decision points.
Expert Q&A on how tumor protein profiling can de-risk oncology programs, delivering novel insights not inferred by genomics.
Query target protein expression across 15+ normal human tissues to establish baseline biological context for drug development.
A unified system for multi-dimensional measurement of functional biology across 12,000+ proteins in human tumors.
Multi-dimensional proteomic characterization across 15+ normal human tissues to de-risk target selection.
How converging innovation cycles have transformed mass spectrometry into a scalable platform for drug development.
How Sapient's multi-omics workflows helped identify an anti-inflammatory signature in early-passage MSC-derived exosomes.
Quantify specific proteins with sequence-confirmed accuracy – without the antibody limitations of ELISA.
Directly measuring the layers of functional tumor biology that shape how a tumor behaves and responds to treatment.
